David S Wolf

US Patent:

7730211, Jun 1, 2010

Filed:

Oct 31, 2007

Appl. No.:

11/933093

Inventors:

Edward Balassanian - Kirkland WA, US
David S. Wolf - Redmond WA, US

Assignee:

Implicit Networks, Inc. - Kirkland WA

International Classification:

G06F 15/16

US Classification:

709246, 709247

Abstract:

A method and system for routing data of an source type to a target type is provided. The system has various routines for converting data in one type into data in another type. In one embodiment, the system receives an indication of a source type and identifies various sequences of routines that can convert the data from the source type to a target type. The system then coordinates the processing of the data by each routines in the sequences to the conversion of the data to the target type. The process of identifying the routines is referred to as “discovery. ” The system also provides an aliasing mechanism by which compatible types can be identified. When identifying a sequence of routines, the system may check for routines that support compatible types. When a sequence of routines is identified, the system caches the identity of the sequence to facilitate identifying that sequence when the data of the source type is to be converted to the target type. The system also uses a mechanism for discovering sequences of routines from other computer systems.

US Patent:

8229897, Jul 24, 2012

Filed:

Feb 3, 2006

Appl. No.:

11/347515

Inventors:

David M. Cannon - Tucson AZ, US
Thomas K. Clark - Tucson AZ, US
Stephen F. Correl - Portland OR, US
Toby L. Marek - Santa Clara CA, US
David M. Wolf - Portland OR, US
Jason C. Young - Portland OR, US
Michael W. Young - Pittsburgh PA, US

Assignee:

International Business Machines Corporation - Armonk NY

International Classification:

G06F 7/00
G06F 17/00
G06F 13/00
G06F 13/28

US Classification:

707679, 707644, 707645, 707646, 707680, 707681, 711162

Abstract:

A technique for implementing policy-aware backup and restore capability in a tiered storage system. If a data set's contents are backed up from the tiered storage system to a backup storage system, metadata for the data set may also be backed up. Prior to the data set being restored from the backup storage system to the tiered storage system, the backed up metadata is restored and processed to determine a tier among the tiered storage pools to which the data set will be restored.

US Patent:

20090254577, Oct 8, 2009

Filed:

Jan 8, 2009

Appl. No.:

12/350839

Inventors:

Edward Balassanian - Kirkland WA, US
David S. Wolf - Redmond WA, US

International Classification:

G06F 17/30

US Classification:

707101, 707E17009

Abstract:

A method and system for routing data of an source type to a target type is provided. The system has various routines for converting data in one type into data in another type. In one embodiment, the system receives an indication of a source type and identifies various sequences of routines that can convert the data from the source type to a target type. The system then coordinates the processing of the data by each routines in the sequences to the conversion of the data to the target type. The process of identifying the routines is referred to as “discovery.” The system also provides an aliasing mechanism by which compatible types can be identified. When identifying a sequence of routines, the system may check for routines that support compatible types. When a sequence of routines is identified, the system caches the identity of the sequence to facilitate identifying that sequence when the data of the source type is to be converted to the target type. The system also uses a mechanism for discovering sequences of routines from other computer systems. These other computer systems may broadcast various sequences of routines which are stored at the receiving computer system. A user may use a switchboard mechanism to direct data of a certain source type to one of the broadcasted sequences. This directing of the data to a certain source effects the routing of the data from one computer system to a device or routine on another computer system.

US Patent:

56354819, Jun 3, 1997

Filed:

Jun 6, 1995

Appl. No.:

8/467339

Inventors:

David Wolf - Palo Alto CA

Assignee:

COR Therapeutics, Inc. - South San Francisco CA

International Classification:

A61K 3836
A61K 3516
C07K 1447
C07K 14745

US Classification:

514 12

Abstract:

Analogs of Factor Xa (Factor Xai) which are inactive as proteases in the prothrombinase reaction are useful in treatment of diseases characterized by thrombosis. These antithrombotic agents can be conveniently prepared using recombinant techniques.

US Patent:

59900792, Nov 23, 1999

Filed:

Jan 30, 1998

Appl. No.:

9/016400

Inventors:

David L. Wolf - Palo Alto CA
Uma Sinha - San Francisco CA

Assignee:

COR Therapeutics Inc. - South San Francisco CA

International Classification:

A61K 3836
A61K 3516
A61F 1300
C07K 14435

US Classification:

514 2

Abstract:

Analogs of blood factors which are transiently inactive are useful in treatment of diseases characterized by thrombosis. In addition, modified forms of activated blood factors that generate the active blood factor in serum but have extended half-lives are useful in treating hemophilia conditions. These modified forms of the blood factor may be acylated forms which are slowly deacylated in vivo.

US Patent:

54967244, Mar 5, 1996

Filed:

May 24, 1993

Appl. No.:

8/067139

Inventors:

Robert M. Scarborough - Belmont CA
David L. Wolf - Palo Alto CA
Israel F. Charo - Lafayette CA

Assignee:

COR Therapeutics, Inc. - South San Francisco CA

International Classification:

C12N 121
C12N 1571
C12N 119
C12N 1512

US Classification:

4352523

Abstract:

An assay for screening snake venom for the presence or absence of platelet aggregation inhibitors (PAIs) based on specific receptor binding is described. Using this assay, the identification and characterization of PAIs in a wide range of snake venom samples was accomplished. The isolated and purified PAI from several of these active snake venoms is described and characterized. In addition, PAIs lacking the Arg-Gly-Asp (RGD) adhesion sequence but containing K*-(G/Sar)-D wherein K* is a modified lysyl residue of the formula R. sup. 1. sub. 2 N(CH. sub. 2). sub. 4 CHNHCO-- wherein each R. sup. 1 is independently H, alkyl(1-6C) or at most one R. sup. 1 is R. sup. 2 --C. dbd. NR. sup. 3 wherein R. sup. 2 is H, alkyl(1-6C) or is NR. sup. 4. sub.

US Patent:

56503148, Jul 22, 1997

Filed:

Jun 6, 1995

Appl. No.:

8/470807

Inventors:

David Wolf - Palo Alto CA

Assignee:

COR Therapeutics, Inc. - South San Francisco CA

International Classification:

C12N 950
C12N 120
C12P 2106
C07H 2104

US Classification:

435219

Abstract:

Analogs of Factor Xa (Factor Xai) which are inactive as proteases in the prothrombinase reaction are useful in treatment of diseases characterized by thrombosis. These antithrombotic agents can be conveniently prepared using recombinant techniques.

US Patent:

58916520, Apr 6, 1999

Filed:

Jun 2, 1995

Appl. No.:

8/460490

Inventors:

David Wolf - Palo Alto CA
James E. Tomlinson - San Francisco CA
Larry J. Fretto - Belmont CA
Neill A. Giese - San Francisco CA
Jaime A. Escobedo - San Francisco CA
Lewis Thomas Williams - Tiburon CA

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

G01N 3350

US Classification:

435 721

Abstract:

Defined constructs of modified human platelet-derived growth factor receptor polypeptides are provided. Extracellular region domain structures are identified and modifications and combinatorial rearrangements of the receptor segments are provided. Both cell bound and soluble forms of modified segments are made available, as are methods for assays using them, allowing for screening of ligand analogues.